Based on the cellular landscape and transcription differences of TAMs after BCL9 suppression, they demonstrated that regulation of Wnt signalling via BCL9 suppression was expected to impair TAM-induced inflammation, CRC progression and immune surveillance (60). This evidence concerns the gene BCL9 and colorectal carcinoma.